In cellular models encompassing ovarian cancer and glioblastoma, the YAP1-MAML2 fusion generates a chimeric protein that activates YAP1-related transcriptional programs through a TEAD1-dependent mechanism, thereby promoting tumor cell proliferation (71, 72). This evidence concerns the gene YAP1 and ovarian carcinoma.